254 related articles for article (PubMed ID: 34699621)
21. miR-134 functions as a tumor suppressor in cell proliferation and epithelial-to-mesenchymal Transition by targeting KRAS in renal cell carcinoma cells.
Liu Y; Zhang M; Qian J; Bao M; Meng X; Zhang S; Zhang L; Zhao R; Li S; Cao Q; Li P; Ju X; Lu Q; Li J; Shao P; Qin C; Yin C
DNA Cell Biol; 2015 Jun; 34(6):429-36. PubMed ID: 25811077
[TBL] [Abstract][Full Text] [Related]
22. circPTCH1 promotes invasion and metastasis in renal cell carcinoma via regulating miR-485-5p/MMP14 axis.
Liu H; Hu G; Wang Z; Liu Q; Zhang J; Chen Y; Huang Y; Xue W; Xu Y; Zhai W
Theranostics; 2020; 10(23):10791-10807. PubMed ID: 32929380
[No Abstract] [Full Text] [Related]
23. The miR-200 family as prognostic markers in clear cell renal cell carcinoma.
Saleeb R; Kim SS; Ding Q; Scorilas A; Lin S; Khella HW; Boulos C; Ibrahim G; Yousef GM
Urol Oncol; 2019 Dec; 37(12):955-963. PubMed ID: 31635993
[TBL] [Abstract][Full Text] [Related]
24. The long intergenic noncoding RNA GAS5 reduces cisplatin-resistance in non-small cell lung cancer through the miR-217/LHPP axis.
Yang X; Meng L; Zhong Y; Hu F; Wang L; Wang M
Aging (Albany NY); 2021 Jan; 13(2):2864-2884. PubMed ID: 33418541
[TBL] [Abstract][Full Text] [Related]
25. Epithelial-mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinoma.
Yoshino H; Enokida H; Itesako T; Tatarano S; Kinoshita T; Fuse M; Kojima S; Nakagawa M; Seki N
J Hum Genet; 2013 Aug; 58(8):508-16. PubMed ID: 23635949
[TBL] [Abstract][Full Text] [Related]
26. Expression and prognostic significance of a comprehensive epithelial-mesenchymal transition gene set in renal cell carcinoma.
Chen D; Gassenmaier M; Maruschke M; Riesenberg R; Pohla H; Stief CG; Zimmermann W; Buchner A
J Urol; 2014 Feb; 191(2):479-86. PubMed ID: 24012533
[TBL] [Abstract][Full Text] [Related]
27. miR-144-3p serves as a tumor suppressor for renal cell carcinoma and inhibits its invasion and metastasis by targeting MAP3K8.
Liu F; Chen N; Xiao R; Wang W; Pan Z
Biochem Biophys Res Commun; 2016 Nov; 480(1):87-93. PubMed ID: 27717821
[TBL] [Abstract][Full Text] [Related]
28. ciRS-7 is a prognostic biomarker and potential gene therapy target for renal cell carcinoma.
Mao W; Wang K; Xu B; Zhang H; Sun S; Hu Q; Zhang L; Liu C; Chen S; Wu J; Chen M; Li W; Peng B
Mol Cancer; 2021 Nov; 20(1):142. PubMed ID: 34740354
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma.
Cui L; Zhou H; Zhao H; Zhou Y; Xu R; Xu X; Zheng L; Xue Z; Xia W; Zhang B; Ding T; Cao Y; Tian Z; Shi Q; He X
BMC Cancer; 2012 Nov; 12():546. PubMed ID: 23173671
[TBL] [Abstract][Full Text] [Related]
30. Tumor suppressive microRNA‑138 contributes to cell migration and invasion through its targeting of vimentin in renal cell carcinoma.
Yamasaki T; Seki N; Yamada Y; Yoshino H; Hidaka H; Chiyomaru T; Nohata N; Kinoshita T; Nakagawa M; Enokida H
Int J Oncol; 2012 Sep; 41(3):805-17. PubMed ID: 22766839
[TBL] [Abstract][Full Text] [Related]
31.
Pan H; Hong Y; Yu B; Li L; Zhang X
Cancer Biother Radiopharm; 2019 Jun; 34(5):334-341. PubMed ID: 30844301
[No Abstract] [Full Text] [Related]
32. MicroRNA-182 suppresses clear cell renal cell carcinoma migration and invasion by targeting IGF1R.
Wang X; Li H; Cui L; Feng J; Fan Q
Neoplasma; 2016; 63(5):717-25. PubMed ID: 27468875
[TBL] [Abstract][Full Text] [Related]
33. miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma.
Lu R; Ji Z; Li X; Zhai Q; Zhao C; Jiang Z; Zhang S; Nie L; Yu Z
J Cancer Res Clin Oncol; 2014 Mar; 140(3):387-97. PubMed ID: 24384875
[TBL] [Abstract][Full Text] [Related]
34. MiR-206 suppresses proliferation and epithelial-mesenchymal transition of renal cell carcinoma by inhibiting CDK6 expression.
Guo Z; Jia H; Ge J
Hum Cell; 2020 Jul; 33(3):750-758. PubMed ID: 32277426
[TBL] [Abstract][Full Text] [Related]
35. High Annexin A5 expression promotes tumor progression and poor prognosis in renal cell carcinoma.
Tang J; Qin Z; Han P; Wang W; Yang C; Xu Z; Li R; Liu B; Qin C; Wang Z; Tang M; Zhang W
Int J Oncol; 2017 May; 50(5):1839-1847. PubMed ID: 28393205
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-588 regulates migration capacity and invasiveness of renal cancer cells by targeting EIF5A2.
Dong JS; Wu B; Zha ZL
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10248-10256. PubMed ID: 31841179
[TBL] [Abstract][Full Text] [Related]
37. Circular RNA circ-EGLN3 promotes renal cell carcinoma proliferation and aggressiveness via miR-1299-mediated IRF7 activation.
Lin L; Cai J
J Cell Biochem; 2020 Nov; 121(11):4377-4385. PubMed ID: 31904147
[TBL] [Abstract][Full Text] [Related]
38. Molecular Characterization of Renal Cell Carcinoma: A Potential Three-MicroRNA Prognostic Signature.
Lokeshwar SD; Talukder A; Yates TJ; Hennig MJP; Garcia-Roig M; Lahorewala SS; Mullani NN; Klaassen Z; Kava BR; Manoharan M; Soloway MS; Lokeshwar VB
Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):464-472. PubMed ID: 29440068
[No Abstract] [Full Text] [Related]
39. MicroRNA-15a tissue expression is a prognostic marker for survival in patients with clear cell renal cell carcinoma.
Mytsyk Y; Borys Y; Tumanovska L; Stroy D; Kucher A; Gazdikova K; Rodrigo L; Kruzliak P; Prosecky R; Urdzik P; Dosenko V
Clin Exp Med; 2019 Nov; 19(4):515-524. PubMed ID: 31440867
[TBL] [Abstract][Full Text] [Related]
40. Long Noncoding RNA Small Nucleolar RNA Host Gene 1 (SNHG1) Promotes Renal Cell Carcinoma Progression and Metastasis by Negatively Regulating miR-137.
Zhao S; Wang Y; Luo M; Cui W; Zhou X; Miao L
Med Sci Monit; 2018 Jun; 24():3824-3831. PubMed ID: 29874202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]